Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-109302
Filing Date
2016-03-17
Accepted
2016-03-17 19:38:30
Documents
1
Period of Report
2016-02-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5756
  Complete submission text file 0001209191-16-109302.txt   7301
Mailing Address C/O CELL GENESYS, INC. 500 FORBES BLVD. S. SAN FRANCISCO CA 94080
Business Address
POTTS JOHN T JR (Reporting) CIK: 0001202447 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37507 | Film No.: 161513892

Mailing Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121
Business Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121 (858) 633-0300
NantKwest, Inc. (Issuer) CIK: 0001326110 (see all company filings)

EIN.: 431979754 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)